Yes, SES significantly influences cancer treatment outcomes. Patients from lower SES backgrounds often experience worse outcomes due to several factors:
Delayed Diagnosis: Lower SES individuals are less likely to undergo regular screenings, leading to later-stage diagnoses when treatment options are limited and less effective. Access to Treatment: Financial constraints may limit access to high-quality treatment options, including innovative therapies and participation in clinical trials. Support Systems: Lower SES individuals may lack robust social support networks, which are crucial for helping patients navigate the complexities of cancer treatment and recovery.
